跳至主要内容
临床试验/KCT0002956
KCT0002956已完成未知

Korean Multicenter Registry of EPIC stent for Iliac Artery Disease: (K-EPIC Registry)

Yonsei University Health System, Severance Hospital0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19(Year) 至 85(Year)(—)
性别
All

入选标准

  • 1) Age 19 years of older
  • 2) Symptomatic peripheral artery disease:
  • - Moderate or severe claudication (Rutherford category 2 or 3)
  • - Critical limb ischemia (Rutherford category 4)
  • 3) Iliac artery lesions with stenosis > 50%
  • 4) ABI <0.9
  • 5) Patents treated with EPIC stent for femoropopliteal artery disease
  • 6) Patients with signed informed consent

排除标准

  • 1) Acute critical limb ischemia
  • 2) Severe critical limb ischemia (Rutherford category 5 or 6)
  • 3) Known hypersensitivity or contraindication to any of the following medications: heparin, aspirin,
  • clopidogrel, cilostazol, or contrast agents
  • 4) In-stent restenosis lesions (Restenosis lesions without previously implanted stents are eligible to
  • the enrollment)
  • 5) Bypass graft lesions
  • 6) Age > 85 years
  • 7) Severe hepatic dysfunction (> 3 times normal reference values)
  • 8) Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding diathesis
  • 9) LVEF < 40% or clinically overt congestive heart failure
  • 10) Pregnant women or women with potential childbearing
  • 11) Life expectancy <1 year due to comorbidity
  • 12) Untreated proximal inflow disease of aorta or the ipsilateral iliac arteries (more than 50%
  • stenosis or occlusion)

研究者

相似试验